M. Salavert

UPDATE IN INTENSIVE CARE MEDICINE: CRITICAL PATIENT WITH SERIOUS INFECTION Role of viral infections in immunosuppressed patients

R. Granada, A. Díaz, M. Salavert, 2017 .

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients

J. Barrueta, D. Rubio-Rodríguez, I. Rodríguez, 2015 .

Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients.

M. Salavert, M. Lizasoáin, J. Gayoso, 2017, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

Á. Estella, E. Cercenado, C. Cillóniz, 2023, Journal of clinical medicine.

Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain.

J. M. Azcona, J. Campos, A. Oliver, 2016, The Journal of infection.

Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023

M. Salavert, Cristóbal M Rodríguez-Leal, Carlos González-Corralejo, 2024, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases.

A. Llorente, I. Pérez-Valero, P. García, 2011, Enfermedades infecciosas y microbiologia clinica.

Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.

P. Martín-Dávila, I. Ruiz-Camps, C. Gudiol, 2024, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.